More AI Patents Than Nvidia, OpenAI and Tesla Combined?
Most people have no idea this company exists. That's because it's on the inside of your smartphone, your computer, and everything else... 99% of Americans don't even know its name. Billionaires have been buying this $50 AI stock hand over fist...
Financials
| Curr Year EPS Estimate | -0.32 |
| Next Quarter EPS Estimate | -0.17 |
| Profit Margin | -8.59% |
| Operating Margin | -19.64 |
| Return on Assets | -0.04 |
| Return on Equity | -0.03 |
| Revenue | 190.9M |
| Earnings Per Share | -0.19 |
| Revenue Per Share | 3.29 |
| Gross Profit | 230,100,000 |
| Quarterly Revenue Growth | 0.23 |
General
| Name | Vanda Pharmaceuticals Inc |
| Ticker | VNDA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 203 |
About Vanda Pharmaceuticals Inc
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's marketed products include HETLIOZ to treat non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its pipeline products include HETLIOZ (tasimelteon) to treat jet lag disorder, insomnia, delayed sleep phase disorder, sleep disturbances in autism spectrum disorder, and pediatric Non-24; Fanapt (iloperidone) for the treatment of bipolar I disorder and Parkinson's disease psychosis, as well as a long acting injectable (LAI) formulation to treat schizophrenia; and Tradipitant (VLY-686), a small molecule neurokinin-1 receptor (NK-1R) antagonist to treat gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia. The company's pipeline products also include VTR-297, a small molecule histone deacetylase inhibitor to treat hematologic malignancies and with potential use as a treatment for various oncology indications; VQW-765, a small molecule nicotinic acetylcholine receptor partial agonist to treat performance anxiety and psychiatric disorders; VHX-896, an active metabolite of iloperidone; and antisense oligonucleotide molecules. In addition, it offers a portfolio of cystic fibrosis transmembrane conductance regulator activators and inhibitors that include VSJ-110 for the treatment of dry eye and ocular inflammation; and VPO-227 for the treatment of secretory diarrhea disorders comprising cholera. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia.
Earnings
Shiba Inu's Shytoshi Kusama Teases 'Extremely Powerful Partnership' -- Coin Themed On Him Rallies 25%
Shiba Inu (CRYPTO: SHIB) lead ambassador Shytoshi Kusama hinted at a major partnership announcement for the blockchain ecosystem on Tuesday, stirring up excitement among enthusiasts.
Trump's Commerce Secretary nominee, Howard Lutnick, vows to sell his business interests in 90 days
WASHINGTON (AP) — Billionaire financier Howard Lutnick, President Donald Trump's choice to lead the Commerce Department, said Wednesday that he would sell all of his business holdings within 90 days.
My TOP Altcoin for Right Now Is... - Ad
Searching for the top investment opportunity in crypto? Look no further. Our $3 report gives you the full scoop. You'll get this exciting token's name, our recommended investment strategy, and growth projections. Time is of the essence with this one...
Stock market today: Asian stocks advance ahead of the Fed's rate decision as panic over AI fades
HONG KONG (AP) — Asian stocks advanced Wednesday in thin Lunar New Year trading following a rebound on Wall Street driven by tech stocks as the panic over Chinese AI company DeepSeek faded.
Apple Surprises Users With Starlink Beta, Teams Up With Elon Musk's SpaceX And T-Mobile To Bring Satellite Texting For iPhone Users In iOS 18.3
Apple has partnered with SpaceX and T-Mobile to bring Starlink satellite texting to iPhones, with a limited beta test rolling out via iOS 18.3, marking a major step toward expanding connectivity in remote areas.
Is This Defi Coin Your Next "10-Bagger" Investment? - Ad
Our #1 pick in decentralized finance is largely overlooked by mainstream investors (for now). This governance token could skyrocket as DeFi adoption surges with the smart money and institutions.
Betting Against Nvidia Again
So much for the Jevons paradox.
Magnificent 7 Earnings Ahead: 3 ETFs To Ride The Wave
Earnings season in full swing, attention on tech giants known as Magnificent 7: 3 ETFs to consider.
Turning Chaos into Cash - Ad
A small-cap stock is profiting from disaster recovery, with big contracts and insider confidence.
Despite chaos over Trump White House's funding pause, FAFSA forms and student loans still available
A temporary freeze imposed briefly this week by the White House on federal grants and loans left many students wondering about the impact to the used to apply for financial aid.
F5 Sees Big Wins in Multi-Cloud, AI Security, and IT Refresh, Analysts Forecast More Upside
F5 Inc (NASDAQ: FFIV) reported strong Q1 results, beating revenue and EPS estimates. The stock gained as analysts raised price targets and expectations for further growth from IT budgets, data center refresh, and AI demand.
The DOGE Agenda (Eight Stocks to Buy) - Ad
Every investor in America is trying to figure out what Musk will do in Washington, D.C. in the coming weeks.
Pauses on US foreign aid and local grants send funders and nonprofits scrambling
NEW YORK (AP) — Freezing . Withdrawing from the . Prohibiting nonprofits that receive U.S. foreign aid .
Hawaii wildfire victims spared from testifying after last-minute deal over $4B settlement
HONOLULU (AP) — Lawyers representing victims of a deadly Hawaii wildfire reached a last-minute deal averting a trial Wednesday to determine how to split a .
The No. 1 Stock for Trump's Second Term? - Ad
Legendary investor Louis Navellier's stock rating system gave a buy rating to ALL of the top 30 performing stocks in the S&P 500 index of Trump's first term... ALL of them! His system is now rating these stocks as a "BUY" for Trump's second term.
Ozempic Receives FDA Approval To Treat Kidney Disease
The FDA on Tuesday approves Ozempic, the weight loss drug made by Novo Nordisk, for the treatment of chronic kidney disease in patients who also have type 2 diabetes.
Frontier makes a second bid for Spirit with budget airlines struggling
NEW YORK (AP) — Frontier Airlines is attempting for a second time to merge with the now bankrupt Spirit Airlines, which declared bankruptcy late last year as budget airlines struggle.
He Called Every Bull And Bear Market In Crypto Since 2012 ... Here's What He Says Is Next - Ad
Juan Villaverde may be America's top crypto expert. According to Juan's timing model, we are entering what could be the biggest bull market in crypto's history. With America's first crypto president in office, it could be the biggest gains the market has ever seen. And one special coin could skyrocket.
Coinbase Taps Trump's Campaign Manager, Chris LaCivita To Tackle Crypto Policy In Washington
Coinbase adds former Trump campaign manager and Senator Sinema to advisory team, highlighting crypto's efforts for influence and clear regulations.
'Mona Lisa' will get its own room under a major renovation of the Louvre
PARIS (AP) — French President Emmanuel Macron announced Tuesday that will get its own dedicated room inside the Louvre museum under a major renovation and expansion of the Paris landmark that will take up to a decade.
Elon Musk: "AI Will Run Out of Electricity ... in 2025" - Ad
This AI boom is going to push America's power grid to the brink... Elon Musk even recently said that AI could run out of electricity by 2025. This crisis may just reveal one of the greatest investment ideas we are ever going to find. My research has recently uncovered two companies that could make a massive difference today.
Robert Kiyosaki Predicts Yet Another Stock Market Crash, Pitches Bitcoin Investments — Here's What The 'Rich Dad Poor Dad' Author Said
Renowned investor and author Robert Kiyosaki on Monday predicted a major stock market crash in February and advised investors to focus on Bitcoin (CRYPTO: BTC), gold, and silver.
7 AI Infrastructure Stocks Plunge Over 20%, Outpace Semiconductor Rout As DeepSeek Upends Investment Landscape
The launch of DeepSeek affects the AI boom including the power, cooling and data center giants that once rode the AI euphoria, which now have single-day losses exceeding 20%.
Stunning Trump Exec Order Leaked - Ad
This secret document contains stunning details about Donald Trump's big Day 1 announcement... His allies are calling it Trump's Secret Manhattan Project. Because if what's in this leaked document is even half true (and trust me, it comes from a very, very credible source)... It will be the boldest, most mind-blowing and daring American initiative ANY U.S. President has launched in over 80 years. And over the next 100 days, it could set off a huge dose of "Trump Market Euphoria"... igniting a buying frenzy in very specific AI stocks... unlike anything we've seen so far.
Hong Kong's snake soup is slithering away but still simmers in a decades-old kitchen
HONG KONG (AP) — As Hong Kong prepares to welcome the Year of the Snake on Wednesday, Chau Ka-ling displays a moving serpent with practiced ease, holding it like a pet in her decades-old restaurant in the city.
Nvidia faces a reckoning as an upstart rival raises questions about Wall Street's darling
NEW YORK (AP) — The superstar run for Nvidia’s stock the last few years has been astonishing. So was its tumble Monday, which caused $595 billion in wealth to vanish. That’s about as much as PepsiCo, McDonalds, Starbucks and Target are worth, combined.
Retire from ONE Stock?! [Ticker Symbol Revealed] - Ad
Jeff Clark has used one stock -- just one -- to show his readers gains of 85% in 14 days, 176% in 5 weeks, 41% in two weeks, 120% in 3 months, 138% in 8 days, 186% in 8 days, 222% in 8 days, and many more... With gains like that, is it really possible to retire from this ONE stock alone?
DeepSeek News Plunges IT Hardware Stocks, But Analyst Sees 5 Bright Spots Among Tech Giants
IT hardware stocks dip after DeepSeek news, but analyst sees growth potential in Corning, Hewlett Packard Enterprise, Western Digital, Seagate Technology and Apple due to specific catalysts.
Lyft Faces Growing Competition, Bank of America Analyst Warns
Bank of America analyst Micheal McGovern reiterated a Buy rating on Lyft and lowered the price target from $21 to $19.
Do NOT Buy Nvidia, Apple, Microsoft, Meta, Tesla, or ANY Major Tech Stock... - Ad
31 billionaires (including: Warren Buffett, Elon Musk, Jeff Bezos, and more) are quietly unloading shares of their OWN stocks at RECORD pace... But why? Wall Street legend Eric Fry says it's because, soon: "America's most popular stocks like Nvidia, Apple, Meta, Tesla, and thousands more... are set to come plummeting back to Earth." Erasing YEARS of investor profits... Sparking a $17 trillion PANIC on Wall Street...
Jeff Bezos-Backed Perplexity Revises TikTok Merger Deal, Proposes Giving US Government 50% Stake: Report
Jeff Bezos-backed Perplexity AI has proposed merging with TikTok's U.S. operations, offering the U.S. government a 50% stake via a $300 billion IPO while allowing ByteDance to retain ties without the proprietary recommendation algorithm.
Bank of America's Sensitive Customer Data Compromised in Third-Party Hack - Is Your Account Safe?
Bank of America (NYSE: BAC) has confirmed a data breach involving a third-party software provider that led to the exposure of sensitive customer data.
He Called Bitcoin to $100k... Now He Says This Coin Is Next - Ad
Juan Villaverde may be America's top crypto expert. According to Juan's timing model, we are entering what could be the biggest bull market in crypto's history. With America's first crypto president in office, it could be the biggest gains the market has ever seen. And one special coin could skyrocket.
DeepSeek Suffers 'Degraded Performance,' Says Hit By 'Large-Scale Malicious Attacks' After Rapidly Emerging As App Store Chart Topper
Chinese AI startup DeepSeek faced significant cyberattacks amid its rapid rise, including topping the U.S. App Store and challenging AI giants with its cost-effective R1 language model.
Fed Set To Signal No Rush To Cut Rates As Wall Street Awaits Policy Clarity
Fed expected to keep rates steady, but Wall Street desperate for clarity on when next cut will come. Markets hoping for a dovish signal, but Powell may not deliver. Odds of two cuts in 2025 at 93%, with $4 payout for single cut and $6 for no cuts.
Buffett, Bloomberg, & 48 Congress Members Are Buying 1 Sector - Ad
Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, "The Walmart Family", Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market... The last time we saw the world's wealthiest investors move their cash into this corner of the market, Stocks exploded 2,020%, 5,609% Even as high as 8,437% in just ONE year. Now, it's all happening again.
How DeepSeek's Breakthrough Is Changing The Landscape For Multi-Industrials
BofA Securities analyst Andrew Obin sees potential growth for multi-industrial stocks like Vertiv Holdings and Eaton Corporation amid the rise of more efficient AI technologies.
South Carolina treasurer calls questions of his role in $1.8 billion accounting error a witch hunt
COLUMBIA, S.C. (AP) — South Carolina Treasurer Curtis Loftis said Wednesday that calls for him to resign over that left the state trying to figure out what happened to a $1.8 billion fund amounted to a witch hunt.
Legendary Investor: Buy These "Trump Stocks" Now - Ad
Within the first week of Trump's election, several stocks exploded for double- and triple-digit gains. According to legendary investor Louis Navellier, this is just the beginning of what could be the best four-year period for stocks in U.S. history.
Elon Musk Faces Criticism From Biographer Over Auschwitz Visit: 'He Truly Is a Sociopath'
Elon Musk has been branded a "sociopath" by his biographer Seth Abramson following the re-emergence of images from Musk's January 2024 visit to Auschwitz.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.